{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:01:08Z","timestamp":1790704868507,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T00:00:00Z","timestamp":1601769600000},"content-version":"am","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.therap.2019.03.004","type":"journal-article","created":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T11:19:18Z","timestamp":1554203958000},"page":"537-546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Non-drug and drug alternatives to benzodiazepines for insomnia in primary care: Study among GPs and pharmacies in a Southwest region of France"],"prefix":"10.1016","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2969-8348","authenticated-orcid":false,"given":"Damien","family":"Driot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Ouhayoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e9lix","family":"Perinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Gr\u00e9zy-Chabard\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Birebent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Bismuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Dupouy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2019.03.004_bib0195","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/fampra\/cmw107","article-title":"High prevalence of insomnia and hypnotic use in patients visiting their general practitioner","volume":"34","author":"Bjorvatn","year":"2017","journal-title":"Fam Pract"},{"key":"10.1016\/j.therap.2019.03.004_bib0200","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.2105\/AJPH.2010.300014","article-title":"The medicalization of sleeplessness: a public health concern","volume":"101","author":"Moloney","year":"2011","journal-title":"Am J Public Health"},{"key":"10.1016\/j.therap.2019.03.004_bib0205","series-title":"\u00c9tat des lieux de la consommation des benzodiaz\u00e9pines","author":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM)","year":"2017"},{"key":"10.1016\/j.therap.2019.03.004_bib0210","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.euroneuro.2015.07.006","article-title":"Benzodiazepines and risk of death: results from two large cohort studies in France and UK","volume":"25","author":"Palmaro","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.therap.2019.03.004_bib0215","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2165\/11531570-000000000-00000","article-title":"Assessment of abuse potential of benzodiazepines from a prescription database using \u201cdoctor shopping\u201d as an indicator","volume":"24","author":"Pradel","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.therap.2019.03.004_bib0220","doi-asserted-by":"crossref","first-page":"g5205","DOI":"10.1136\/bmj.g5205","article-title":"Benzodiazepine use and risk of Alzheimer's disease: case-control study","volume":"349","author":"Billioti de Gage","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.therap.2019.03.004_bib0225","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2165\/00023210-200317110-00004","article-title":"Benzodiazepines and risk of hip fractures in older people: a review of the evidence","volume":"17","author":"Cumming","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.therap.2019.03.004_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00228-012-1424-1","article-title":"Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and z-drugs consumption in nine European countries","volume":"69","author":"Clay","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.therap.2019.03.004_bib0235","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.sleep.2015.10.003","article-title":"Sleep-promoting medications in children: physician prescribing habits in Southwestern Ontario Canada","volume":"17","author":"Bock","year":"2016","journal-title":"Sleep Med"},{"key":"10.1016\/j.therap.2019.03.004_bib0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.smrv.2014.12.003","article-title":"Herbal medicine for insomnia: a systematic review and meta-analysis","volume":"24","author":"Leach","year":"2015","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.therap.2019.03.004_bib0245","article-title":"Antidepressants for insomnia in adults","volume":"5","author":"Everitt","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.therap.2019.03.004_bib0250","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/YIC.0000000000000046","article-title":"Lasting treatment effects in a postmarketing surveillance study of prolonged-release melatonin","volume":"30","author":"Hajak","year":"2015","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.therap.2019.03.004_bib0255","doi-asserted-by":"crossref","first-page":"e76499","DOI":"10.1371\/journal.pone.0076499","article-title":"Misuse and dependence on non-prescription codeine analgesics or sedative H1 antihistamines by adults: a cross-sectional investigation in France","volume":"8","author":"Roussin","year":"2013","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.therap.2019.03.004_bib0260","article-title":"Over-the-counter agents for the treatment of occasional disturbed sleep or transient insomnia: a systematic review of efficacy and safety","volume":"17","author":"Culpepper","year":"2015","journal-title":"Prim Care Companion CNS Disord"},{"issue":"6","key":"10.1016\/j.therap.2019.03.004_bib0265","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1331\/JAPhA.2012.12051","article-title":"Histamine-1 receptor antagonism for treatment of insomnia","volume":"52","author":"Vande Griend","year":"2012","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"2","key":"10.1016\/j.therap.2019.03.004_bib0270","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/acm.2014.0113","article-title":"The effects of aromatherapy on sleep improvement: a systematic literature review and meta-analysis","volume":"21","author":"Hwang","year":"2015","journal-title":"J Altern Complement Med"},{"key":"10.1016\/j.therap.2019.03.004_bib0275","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.smrv.2009.11.005","article-title":"Homeopathy for insomnia: a systematic review of research evidence","volume":"14","author":"Cooper","year":"2010","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.therap.2019.03.004_bib0280","doi-asserted-by":"crossref","first-page":"e63773","DOI":"10.1371\/journal.pone.0063773","article-title":"Meta-analysis: melatonin for the treatment of primary sleep disorders","volume":"8","author":"Ferracioli-Oda","year":"2013","journal-title":"PloS One"},{"issue":"619","key":"10.1016\/j.therap.2019.03.004_bib0285","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.3399\/bjgp14X677176","article-title":"GPs\u2019 management strategies for patients with insomnia: a survey and qualitative interview study","volume":"64","author":"Everitt","year":"2014","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.therap.2019.03.004_bib0290","doi-asserted-by":"crossref","first-page":"191","DOI":"10.7326\/M14-2841","article-title":"Cognitive behavioral therapy for chronic insomnia: a systematic review and meta-analysis","volume":"163","author":"Trauer","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.therap.2019.03.004_bib0295","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/jsr.12594","article-title":"European guideline for the diagnosis and treatment of insomnia","volume":"26","author":"Riemann","year":"2017","journal-title":"J Sleep Res"},{"key":"10.1016\/j.therap.2019.03.004_bib0300","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/jamainternmed.2015.6058","article-title":"Association of off-label drug use and adverse drug events in an adult population","volume":"176","author":"Eguale","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.therap.2019.03.004_bib0305","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/fcp.12140","article-title":"Adverse drug reactions to self-medication: a study in a pharmacovigilance database","volume":"29","author":"Berreni","year":"2015","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.therap.2019.03.004_bib0310","first-page":"148","article-title":"The ECOGEN study: elements of the consultation in general practice","volume":"114","author":"Letrilliart","year":"2014","journal-title":"Exercer"},{"key":"10.1016\/j.therap.2019.03.004_bib0315","first-page":"56S","article-title":"How do GPs consider to participate in research in their field?","volume":"22","author":"Supper","year":"2011","journal-title":"Exercer"},{"key":"10.1016\/j.therap.2019.03.004_bib0320","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.sleep.2006.02.003","article-title":"Progetto Morfeo Committee. Studio Morfeo 2: survey on the management of insomnia by Italian general practitioners","volume":"7","author":"Terzano","year":"2006","journal-title":"Sleep Med"},{"key":"10.1016\/j.therap.2019.03.004_bib0325","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2869.2009.00769.x","article-title":"Sleep problems in general practice: a national survey of assessment and treatment routines of general practitioners in Norway","volume":"19","author":"Sivertsen","year":"2010","journal-title":"J Sleep Res"},{"key":"10.1016\/j.therap.2019.03.004_bib0330","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/ijpp.12052","article-title":"Management of over-the-counter insomnia complaints in Australian community pharmacies: a standardized patient study","volume":"22","author":"Kashyap","year":"2014","journal-title":"Int J Pharm Pract"},{"key":"10.1016\/j.therap.2019.03.004_bib0335","article-title":"Benefits and risks of benzodiazepines and Z-drugs: comparison of perceptions of GPs and community pharmacists in Germany","volume":"11","author":"Hoffmann","year":"2013","journal-title":"Ger Med Sci GMS E-J"},{"key":"10.1016\/j.therap.2019.03.004_bib0340","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1071\/PY12021","article-title":"Primary health care practitioner perspectives on the management of insomnia: a pilot study","volume":"20","author":"Cheung","year":"2014","journal-title":"Aust J Prim Health"},{"key":"10.1016\/j.therap.2019.03.004_bib0345","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1365-2753.2009.01186.x","article-title":"General practitioners\u2019 preferences for managing insomnia and opportunities for reducing hypnotic prescribing","volume":"16","author":"Siriwardena","year":"2010","journal-title":"J Eval Clin Pract"},{"key":"10.1016\/j.therap.2019.03.004_bib0350","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1192\/bjp.bp.107.036301","article-title":"Management of insomnia: treatments and mechanisms","volume":"191","author":"Wilson","year":"2007","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.therap.2019.03.004_bib0355","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3122\/jabfm.17.3.212","article-title":"Treatment of primary insomnia","volume":"17","author":"Ringdahl","year":"2004","journal-title":"J Am Board Fam Pract"},{"key":"10.1016\/j.therap.2019.03.004_bib0360","series-title":"Prise en charge du patient adulte se plaignant d\u2019insomnie en m\u00e9decine g\u00e9n\u00e9rale","author":"Soci\u00e9t\u00e9 de formation th\u00e9rapeutique du g\u00e9n\u00e9raliste (SFTG)","year":"2007"},{"key":"10.1016\/j.therap.2019.03.004_bib0365","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/eurheartj\/ehi262","article-title":"Evidence-based vs \u201cimpressionist\u201d medicine: how best to implement guidelines","volume":"26","author":"Bassand","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.therap.2019.03.004_bib0370","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/acps.12338","article-title":"Effectiveness of the implementation of guidelines for anxiety disorders in specialized mental health care","volume":"132","author":"van Dijk","year":"2015","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.therap.2019.03.004_bib0375","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4088\/JCP.12r07757","article-title":"Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review","volume":"74","author":"McHugh","year":"2013","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.therap.2019.03.004_bib0380","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1093\/sleep\/32.12.1549","article-title":"\u201cStepped Care\u201d: a health technology solution for delivering cognitive behavioral therapy as a first line insomnia treatment","volume":"32","author":"Espie","year":"2009","journal-title":"Sleep"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595719300599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595719300599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T18:53:14Z","timestamp":1758567194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595719300599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0040595719300599"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2019.03.004","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-drug and drug alternatives to benzodiazepines for insomnia in primary care: Study among GPs and pharmacies in a Southwest region of France","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2019.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}